Michael Ruppert

Michael Ruppert

“I can tell you, Director Deutch, emphatically and without equivocation, that the Agency has dealt drugs in this country for a long time.”

A former cop said that. To the face of the Director of the CIA. On camera. And the most powerful spy in America had no answer.

Here’s how that moment happened.

November 15, 1996. South Central Los Angeles. The city was on fire with rage. A journalist named Gary Webb had just published a series called Dark Alliance, alleging the CIA was tied to the Contra rebels and the crack cocaine flooding the streets. People who had buried family in the crack epidemic wanted answers.

So the CIA did something it almost never does. It sent its own director into the room. John Deutch. The head of the entire agency. He came to a town hall at Locke High School to calm the crowd. C-SPAN was rolling.

Then a man stood up and took the microphone.

His name was Michael Ruppert. Former LAPD narcotics detective. UCLA graduate. He’d joined the force in 1973 at 22 wanting to fight crime, and they put him on the most dangerous streets in Los Angeles. And starting in the late 1970s, he said, he saw something he was never supposed to see. A drug network that ran far above the street dealers. He said it reached into the government itself.

He said he got death threats. He said there were attempts on his life. He resigned in 1978, even with the highest performance ratings the department gave. And for almost twenty years, almost nobody listened. They called him crazy. A conspiracy guy. The system had thrown him away.

Now he was standing in front of the Director of the CIA with a microphone in his hand.

He looked Deutch in the eye and said it. The Agency has dealt drugs in this country for a long time.

The room erupted. People roared. They were finally hearing someone say out loud, to the most powerful spy in America, the thing they had lived through. Ruppert kept going. He named three secret operations he claimed to know about. Amadeus. Pegasus. Watchtower. He said he had documents. He said CIA officers had tried to pull him into protecting these operations back in the 1970s.

Deutch stood there. Cornered. No real answer. The clip went everywhere.

Now here’s the honest part, because the truth matters more than a clean story.

Ruppert never proved those three operations. Amadeus, Pegasus and Watchtower are still his claims and nothing more. No declassified document has ever confirmed them. To this day they remain allegations.

But the bigger thing he was shouting about did not go away.

In 1998, the CIA’s own Inspector General released a report. And buried in the careful language was an admission. The agency had worked with dozens of people tied to the Contras who were involved in drug trafficking. In at least six cases, it knew about the drug allegations and kept working with them anyway. It didn’t cut ties. The CIA’s own watchdog confirmed the relationship Ruppert and Gary Webb had been screaming about for years.

Not every claim was true. But the core was not crazy. The most powerful intelligence agency on earth really had climbed into bed with drug traffickers. And the government’s own report said so in writing.

That’s the part that should stop you.

A discarded ex-cop, mocked for twenty years, stood up in a high school gym and accused the CIA of dealing drugs to the director’s face. Then a federal report quietly proved the heart of it. And the question he forced into the open that day, who really protected the people poisoning American streets, has never been fully answered.

He didn’t win in a courtroom. He didn’t get an apology. He won the moment. He made the most powerful agency in America stand in front of a camera and have no answer.

One cop. One microphone. One sentence the CIA could not make disappear. And a question that is still sitting there, unanswered, all these years later. One cop, one microphone, one question the most powerful spy in America couldn’t answer and it’s still unanswered today.

Send it forward and be the reason that question keeps getting asked long after they hoped it died.

Bruno Lafont

Bruno Lafont

Last month, while a judge in a Paris courtroom finished reading her verdict, police walked over and arrested Bruno Lafont. He’s 69, the former CEO of Lafarge, the largest cement manufacturer in the world. He’s now serving a 6 year prison sentence, and his former second-in-command is serving 5.

When corporations cause real harm in pursuit of profit, when they poison rivers, flood communities with deadly drugs, or fund violence to keep a factory running, the typical outcome is a fine. The company pays out, the executives keep their jobs or retire quietly or move on to a board seat somewhere else, and almost no one personally goes to prison. We see this massively in the pharmaceutical field.

But this ruling may change things moving forward.

What Lafarge actually did

Between 2013 and 2014, as Syria collapsed into civil war, Lafarge paid roughly 6.5 million dollars to ISIS and two other groups designated as terror organizations. The payments bought safe passage through ISIS checkpoints, which meant the company’s Syrian cement plant could keep running and keep generating revenue.

Nobel laureate Nadia Murad and more than 400 other Yazidi survivors, all of them American citizens, eventually sued Lafarge directly. Their argument was that the company’s payments helped finance the genocide of the Yazidi people, the mass executions, the sexual slavery, the abduction of thousands of women and children.

According to the lawsuit, Lafarge’s own cement was even used to construct the underground tunnels and bunkers where ISIS held Yazidi hostages captive.

While the European staff at the plant were evacuated to safety, the Syrian workers were told to keep working, crossing checkpoints under sniper fire, risking kidnapping, showing up to a job inside an active war zone because the cement had to keep flowing.

The judge, in delivering her verdict, said something that has stayed with me since I read it. “I am trying to make you understand,” she told the executives, “how choices made in your offices, thousands of kilometers away, turned into Kalashnikov bullets, into blood.”

This level of downline thinking is what responsibility looks like. It’s what we have been trying to offer to our readers for 17 years, the idea that as a culture, we have to think more deeply about what we’re creating and what effects it has downline, vs. thinking about more short term gratifications.

In defense, Lafont told the court he hadn’t read the emails documenting the payments. His exact line, which I cannot improve on, was “I’m not a child of the internet.” His former deputy was more direct in that he admitted in court that the groups receiving the payments had been described, in writing, as “hard-core terrorists,” and that he kept authorizing payments to them anyway. When the judge pressed him, he said they had a choice between two bad options. The judge asked, “The worst one and the less bad one?” “Exactly,” he replied.

Translated out of legalese, the defense was not surprisingly: “We were faced with losing profit or funding terror, and we chose the less expensive option for the company.”

These types of decisions are being made all over the place in our world within it’s current design. CEO’s follow incentive and fiduciary responsibility, which in essence provides them plausible deniability in most cases.

To be clear, this isn’t really a story about individually wicked men, it’s a story about a system that trains its decision-makers to weigh two things on the same scale and choose whichever one protects revenue. The race to the bottom logic baked into modern incentive structures is doing a lot of the moral work here, long before any individual executive signs off on a payment.

The court ultimately did not buy the CEO’s story and Judge Isabelle Prévost-Desprez called the conduct “stunningly cynical.” She fined the company €1.12 million, ordered the confiscation of €30 million in assets, and sent the executives to prison.

Why this matters more than the fine

To understand why this verdict is a big deal, you have to understand what hasn’t been happening for the last eight decades.

The most directly comparable case goes back to 1947, when executives of I.G. Farben, the German chemical company that supplied the gas used in Nazi concentration camps, were tried at Nuremberg. Most were acquitted. The few who were convicted received light sentences that were quietly commuted not long after. The legal precedent that a corporation and its leaders could be criminally accountable for the violence their products enabled was established, and then more or less left to sit on a shelf for 80 years.

In the meantime, when corporations have been found liable for harming people, the standard response has been a fine. In many cases, those fines get absorbed as a normal cost of doing business, paid out of one revenue stream while the rest keep flowing untouched.

When the fines get big enough to actually threaten profit, the response has often been overwhelming retaliation against whoever is fighting for justice. Chevron, for example, spent roughly 2 billion dollars dragging out a legal war against the lawyer who beat them in Ecuadorian court for poisoning the Amazon.

A fine is a transaction, but a prison sentence is something else entirely. It changes who, personally, is on the line, and that changes the way companies will operate form there on out. The system needs accountability, or else incentives will always win out.

The good news is that this verdict is a real crack in the assumption that corporate decision-makers can operate at a safe altitude above the consequences of what their companies actually do in the world.

But here is where I want to slow down a little, because there’s a fair question that still needs to be asked here:

Why did this one end in prison sentences when Chevron in Ecuador didn’t? When Purdue Pharma’s executives walked? Or Pfizer’s or Monsanto’s or Big Tobacco’s?

One honest part of the answer is that Lafarge’s payments helped fund a network that eventually killed French civilians on French soil. That made the politics of prosecution very different from the politics of poisoning Indigenous rivers in the Amazon, or flooding rural American towns with opioids, or any number of other harms that fall outside what Western states are willing to call a serious crime.

The legal systems we have are largely the same ones that have historically protected capital’s right to extract from communities deemed expendable.

So this verdict is a real step forward, and at the same time, it’s a reminder of where the line currently sits for who gets protected and who doesn’t. Both things can be true. The win is real, and the asymmetry is real, and pretending otherwise is just another way of not seeing the situation clearly.

What’s next

A few related cases are already moving. Starting in July of this year, EU member states will require large companies to identify and address human rights and environmental harms across their supply chains, with actual consequences for failure.

Last October, a federal jury in New York found BNP Paribas liable for aiding atrocities in Sudan. The Lundin Oil trial in Sweden, which looks structurally similar to Lafarge, is expected to deliver a verdict soon. The next Lafarge trial, this one on charges of complicity in crimes against humanity, will likely follow.

There is also reasonable concern about backlash. A US administration that has sanctioned a UN rapporteur for documenting corporate complicity in Gaza, presided over a 660 million dollar verdict against Greenpeace for opposing an oil pipeline, and dismantled large parts of the EPA’s regulatory powers is not going to quietly accept a wave of accountability rulings.

The process of accountability is not fast or easy. I’ve been doing this work for 17 years and most of the stories I’ve followed or talked about don’t end up in real accountability. Pfizer’s C0VID vax trials were fraudulent, we’re not even talking about that anymore. Look at the lack of Epstein network accountability. This isn’t meant to get us down, but to realie the power of the system at hand and maintain our sense of resilience in working toward a better world.

Ultimately, this all has to still move through courtrooms, through journalism, through people who are willing to spend years pressing on a story that powerful interests would much rather have buried. None of those tools is sufficient on its own, but together, slowly, they shift what powerful people can get away with.

The good news is, the judge in Paris drew a line that hasn’t really been drawn in 80 years, and that line now exists. What we choose to build on top of it is the next question.

`

Quote of the Day

“You cannot teach a man anything; you can only help him find it within himself.” – Galileo Galilei (1564 – 1642)

I have heard this from other wise men and personally observed the inability to impart data to those ‘who do not have it within themself’.

I also helps partially explain the failures many of have had over the last 6 years trying to impart to others what seems to be obvious and incontrovertible truths.

Catherine Mohr

Catherine Mohr

There is a question that seems almost impolite to ask about medicine:

What if the tools are wrong?

Not the surgeons. Not the training. Not the dedication or the intelligence or the years of practice that go into becoming someone who can hold a life in their hands and steady it.

The tools. The physical instruments. The fundamental mechanics of how surgery is performed on a human body.

Catherine Mohr asked that question. And the answer she arrived at changed what surgery looks like for millions of people who will never know her name.

Mohr came to medicine from the outside — from mechanical engineering, from a professional world governed by physics and mathematics and the unforgiving principle that a system either performs to specification or it doesn’t.

In that world, when a design has limitations, you don’t celebrate the limitations as tradition. You identify them, study them, and engineer your way around them.

When she turned that analytical attention toward surgery, what she saw was this:

Human hands — even the steadiest, most skilled, most brilliantly trained surgical hands in the world — tremble. Microscopically, involuntarily, physiologically. It is not weakness. It is biology.

Human wrists rotate and bend only within the ranges that bone and connective tissue allow. They cannot articulate at the angles that internal anatomy sometimes demands for optimal surgical access.

Incisions have to be made large enough to accommodate human hands and forearms — far larger, in many cases, than the actual surgical work requires — simply because there is no other way to get skilled human hands to the place they need to be.

Surgeons were extraordinary. Their tools were, by engineering standards, primitive.

The question Mohr and a growing community of engineers and surgeons began asking in the late 1980s and 1990s was direct: what if you could extend the surgeon’s capabilities past what human anatomy allows?

Not replace the surgeon. Not remove judgment or skill or the irreplaceable human relationship between physician and patient.

Extend it. Give the surgeon’s expertise a more precise physical expression than bare hands inside a body cavity could provide.

The development of what became the da Vinci Surgical System was a collaborative effort across years and institutions — DARPA-funded research, work at SRI International, the founding vision of engineers like Frederic Moll, and the contributions of dozens of researchers, physicians, and engineers who each brought something essential to a problem that no single person could solve alone.

Catherine Mohr was part of that effort at Intuitive Surgical — contributing to the development, testing, and refinement of systems that would need to earn the trust of a medical establishment deeply and reasonably skeptical of machines in operating rooms.

That skepticism was not irrational. It was responsible.

Surgery is intimate. Tactile. The haptic feedback of feeling tissue resistance with your own hands is real clinical information. The concerns about mechanical failure, software errors, loss of power during critical procedures — these were legitimate questions requiring rigorous answers, not obstacles to be dismissed.

The answer was data.

Clinical outcomes. Controlled studies. Peer-reviewed research accumulated over years, procedure by procedure, specialty by specialty, showing measurable improvement in the things that matter most to patients: blood loss, recovery time, post-operative pain, complication rates, time before returning to normal life.

What the technology delivered was a transformation in the mechanics of surgery itself.

Robotic instruments — tiny, far smaller than human fingers — could rotate through seven degrees of freedom, articulating at angles a human wrist cannot achieve. Involuntary tremors were filtered algorithmically, translated into perfectly smooth movements. The surgical field was magnified and rendered in high-definition three-dimensional imaging, giving surgeons a view of their work dramatically superior to what the naked eye could see through a traditional incision.

Surgeons operated from an ergonomic console, their natural hand movements translated in real time into precise, scaled motions inside the patient’s body. The learning curve was real but manageable — the system was designed to work with surgeons’ existing motor skills, not demand they develop entirely new ones.

Incisions that once had to be 15 to 30 centimeters to accommodate human hands could become 1 to 2 centimeters. Recoveries that took 6 to 8 weeks from major open surgery became days.

The resistance from the medical establishment did not vanish overnight — it never does, and it shouldn’t. Medicine changes slowly because the cost of being wrong is paid by patients. But the evidence accumulated until it was impossible to responsibly ignore.

Today, robotic-assisted surgery is a standard of care across cardiac, urological, gynecological, thoracic, colorectal, and dozens of other surgical specialties worldwide. Millions of procedures are performed every year using systems built on principles that a generation ago seemed like science fiction to most of the surgeons now using them routinely.

Patients leave hospitals in days. Scars are barely visible. Pain is substantially reduced. Lives that would have required months of recovery return to normal in weeks.

The people who benefited from this transformation will mostly never know the names of the engineers who made it possible — not Mohr, not Moll, not the researchers at SRI International, not the dozens of others who contributed essential pieces to a puzzle that took decades to complete.

They will know only the faster healing. The smaller scar. The afternoon they felt well enough to sit outside and watch their children play, weeks sooner than the surgery they needed once would have allowed.

Catherine Mohr has spent years not only contributing to surgical robotics but explaining it — making the case to medical communities, to patients, to anyone willing to listen, for why questioning whether a tool is optimal is not disrespect for the people who use it but respect for the patients who depend on it.

She understood something that takes genuine intellectual courage to hold onto in the face of institutional resistance:

Tradition and optimality are not the same thing.

A practice can be respected, long-established, performed by brilliant and dedicated people — and still have room for improvement. The two things are not in conflict. The willingness to ask whether we can do better is not a criticism of everyone who came before. It is the continuation of the same commitment to patient welfare that motivated every surgeon who came before.

The operating room looked different to Catherine Mohr than it did to most people who walked into it.

She saw, alongside the skill and the dedication and the years of training, a mechanical problem. A gap between what surgeons needed to accomplish and what human hands could physically provide.

She spent her career helping to close that gap.

Millions of people healed faster because she did.

That’s not just engineering. That’s what engineering is for.

No Studies

No Studies

“There are NO saline placebo-controlled studies looking at the hepatitis B vaccine risk given to day-old newborns.” “Why?” “Here’s what you’ll be told by the… so-called authorities.” Dr. Suzanne Humphries exposes the excuses for why vaccines can’t be properly safety tested: “We’re told that it’s unethical to do a saline placebo study now because the safety was long ago established.” “Hepatitis B vaccines that we’re using today were licensed based on immunogenicity.” “[They’ve done] some short-term safety monitoring for a few days in some uber-healthy infants and a small group of premature, low birth weight infants for sure.” “[They’ve done] comparisons that sometimes used aluminum-containing placebos or other controls rather than pure saline.” “And we know that this is a common practice… by supposed vaccine scientists to use another vaccine that contains an inflammatory agent.” “They say because it will make it less obvious who received the placebo.” “And the other reason is ‘we don’t want to deprive the placebo group from something beneficial.’” “What a riot.”

https://x.com/ChildrensHD/status/2066143626246201350?s=20

The Top 7 Indicators ALL “Vaccines” Are a Massive Scam

Massive Scam

An Original Video Essay

Use this video to one-shot any pro-“vaccine” argument!

And please share it if you also think ALL “vaccines” are just worthless poisons

Reason #1: All “vaccines” are protected by an unconstitutional liability shield (timestamp: 1:59)

Reason #2: “Vaccines” don’t actually work at all. They’ve saved zero lives (timestamp: 6:59)

Reason #3: Physicians are incentivized by grotesque amounts of money to inject people, particularly babies and children, with “vaccines” (timestamp: 12:43)

Reason #4: “Vaccines” are unavoidably unsafe. It is literally impossible to make a safe “vaccine” (timestamp 17:31)

Reason #5: “Vaccines” are not well regulated. Almost anything can be a “vaccine,” and “vaccines” have never been regulated like other drugs (timestamp 23:30)

Reason #6: “Unvaccinated” people are far, far healthier than “vaccinated” people (timestamp: 26:50)

Reason #7: “Vaccines” cause catastrophic, sometimes fatal, “side effects.” “Vaccines” have ruined an untold number of lives, and they will continue to do so as long as they’re available (timestamp 32:20)

Click to view the video: https://x.com/SenseReceptor/status/2066224232636534949?s=20

Dr Russell Blaycock on Tetanus

Dr Russell Blaycock on Tetanus

Dr. Russell Blaylock: “The tetanus vaccine is one of the MOST RIDICULOUS vaccines ever.”

Just got a cut or puncture wound? The ER is about to BULLY you into a TOXIC shot you don’t need. Here’s what they won’t tell you: The shot they push is NOT a simple tetanus vaccine — it’s the full DTaP combo loaded with:
• Aluminum (up to 0.625 mg — a known neurotoxin)
• Formaldehyde
• 2-phenoxyethanol + Triton X-100
• Milk protein (casein) & latex residues that can trigger anaphylaxis or CREATE new dairy/latex allergies

The tetanus toxoid inside has NEVER been properly safety-tested in a double-blind placebo-controlled trial. CDC admits it.

It’s grown on beef heart infusion with real risk of Mad Cow prion contamination. Your actual chance of getting tetanus? 1 in 11 MILLION. Spores live in manure, NOT rust. Clean the wound properly — oxygen kills them.

95% of the decline happened BEFORE any vaccine thanks to sanitation.

If you’re already exposed, the shot is useless — it takes 3-8 weeks for antibodies.

But high-dose Vitamin C (1–3g/day) cured 100% of cases in studies with ZERO deaths. Cheap. Safe. Ignored.

Why are we terrorized into this untested, poison-filled combo shot for a disease that’s basically extinct in clean countries? Because fear sells.

Don’t fall for the rusty nail myth. Clean the wound. Monitor it. Refuse the jab.

Were you guilt-tripped into a “tetanus shot?” Were you ever told it was actually the full DTaP?

Dr Robert Malone

Dr Robert Malone

“Don’t make it hard – just take care of yourself and your family. Eat healthy food, cut out the junk, don’t overindulge (limited intake), exercise, don’t drink too much, get outside, and enjoy life.”
– Dr. Robert Malone